Company Information

The Company

PhytoMyco Research Pvt. Ltd. (PhytoMyco) is dedicated to the discovery and development of new and safe natural product-based drugs for the treatment of diseases and disorders associated with diabetes, inflammation and infective conditions. The company's focus is the development of a portfolio of botanically derived products ranging from nutraceuticals to prescription pharmaceuticals.

The company's lead products is in the late stage of development for the treatment of diabetes. Products in the Research and Development stage include compounds targeting tuberculosis and drug resistant bacteria. All of the company's portfolio of products originated from one of the largest and unique natural product library collections in the country. This library contains over 16,000 phytochemicals isolated/purified from indigenous plants cultivated by us in south India.

The company is organized into two key business divisions, PhytoMyco Development; this R&D unit invests in developing proprietary science based products for commercialization. PhytoMyco CRO; a source of revenue generation by providing services to pharma, biotech, cosmetic and nutraceutical companies. PhytoMyco is presently located in a prime industrial area with a built in areas consisting of: 2000 sq ft. laboratory/QC space and Greenhouse/shade net facility.

Strategy

The company strategy is to use its broad natural product expertise to develop a portfolio of botanically derived prescription drugs and nutraceuticals, while simultaneously generating revenues and licensing fees from CRO activities and partnerships. PhytoMyco has identified a number of botanical derived candidates of potential therapeutic value in Diabetes, infectious diseases and inflammation. By selecting drug candidates whose efficacy and safety have already been established over hundreds of years in Ayurveda and other traditional medicine, PhytoMyco expects to be able to reduce the time taken to bring these products to market. Also, PhytoMyco is a supplier of natural product libraries, cosmetic and nutraceutical ingredients, and related services. PhytoMyco’s unique lines of cosmetic ingredients are standardized botanicals that have strong scientific support and the ability to achieve perceptible improvement in the health, and appearance of the skin.

The Management Team

The company was founded by Ven Subbiah, Ph. D. with a vision to establish a botanical based company that addresses health issues such as diabetes, inflammatory and infectious diseases. The Research and product development at PhytoMyco aims to serve the global market by cost effective solutions backed by critical clinical evaluations. He is supported by a team of well accomplished professionals who share his vision.

Ven Subbiah, Ph. D. Founder/Chairman:

Dr. Ven Subbiah is Founder/Chairman, has been a serial entrepreneur and founded BoProcess, LLC and PhytoPharmacon, Inc in the United States. He worked as Principal Investigator at RJR-Nabisco and was Senior Research Scientist at OSI Pharmaceuticals, Uniondale, NY, USA. Dr. Subbiah has published 80 papers, and has 35 issued and pending patents. Dr. Subbiah also has two Adjunct Professor position at N. C. State University, Raleigh, NC and East Carolina University, Greenville, NC.

 

 

Mr. Sridhar Gopal, MBA. Business Development Consultant

Mr. Sridhar Gopal, MBA. Business Development Consultant, he has over 20 years experience in the business development, particularly working with start-ups and small biotech companies.

 

Dr. Laxmansa C. Katwa, Ph. D. Director

Dr. Laxmansa C. Katwa, Ph. D. Director, has over 25 years of biomedical research experience to his credit, initially with enzymes/immobilized enzymes involved in food and beverage industry.